摘要
目的:分析小儿哮喘急性发作中孟鲁司特联合布地奈德雾化吸入治疗的效果。方法:时间段为2018年6月至2019年8月,选取患儿为哮喘急性发作80例,随机分组,两组各40例。采用布地奈德雾化吸入治疗控制组,基于此联合孟鲁司特治疗实验组。比较两个组别症状消失时间及疗效。结果:两个组别哮鸣音、湿啰音、憋喘、咳嗽等症状消失时间对比表现出明显差异(P<0.05)。两个组别治疗有效率(控制组75.0%VS实验组92.5%)对比表现出明显差异(P<0.05)。结论:小儿哮喘急性发作中孟鲁司特联合布地奈德雾化吸入治疗的效果显著,即可有效、快速消除患儿各种症状,且安全可靠,值得研究和推广。
Objective:To analyze the effect of Montelukast Combined with budesonide inhalation in children with acute asthma.Methods:From June 2018 to August 2019,80 children with acute asthma attack were randomly divided into two groups,40 in each group.Budesonide atomization inhalation treatment control group,based on this combination of montelukast treatment experimental group.The time and effect of symptom disappearance were compared between the two groups.Results:There were significant differences between the two groups(P<0.05).There was significant difference between the two groups(75.0%control group vs 92.5%experimental group)(P<0.05).Conclusion:Montelukast Combined with budesonide in the treatment of acute attack of childhood asthma is effective,rapid and safe,and worthy of study and promotion.
作者
毕金洲
Bi Jin-zhou(Pingyuan First People’s Hospital,Dezhou Shandong 253100,China)
出处
《医学食疗与健康》
2020年第3期13-13,16,共2页
Medical Diet and Health
关键词
小儿哮喘急性发作
孟鲁司特
布地奈德
雾化吸入
Acute Attack of Childhood Asthma
Montelukast
Budesonide
Aerosol Inhalation